选择透析与保守治疗患者的生存比较:系统综述与Meta分析
该系统综述与Meta分析比较了明确选择透析或保守治疗的肾衰竭患者的生存结局,共纳入22项队列研究、21 344例患者。12项研究调整后死亡风险汇总HR为0.47(95%CI 0.39-0.57),支持透析组死亡风险更低;但偏倚风险高、报告异质性大,无法得出确定性结论,结果不能推广至个体。
要点
- 选择透析的患者较选择保守治疗者更年轻、合并症更少、功能损害更少、衰弱更轻
- 12项研究调整后死亡风险汇总HR为0.47(95%CI 0.39-0.57),透析组低于保守治疗组
- 多数研究存在选择偏倚和混杂,偏倚风险高且报告异质性大,结论不能推广至个体
核心结论
- 选择透析的患者与选择保守治疗的患者相比,总体死亡风险更低
- 高偏倚风险和异质性报告使确定性结论无法得出,结果不能转化至个体层面
研究设计与样本
- 系统综述与Meta分析,系统检索5个数据库自建库至2021年2月25日的文献
- 纳入22项比较选择透析与保守治疗患者生存结局的队列研究,共21 344例患者
- 提取调整与未调整生存率并在适用时进行Meta分析,按Cochrane非随机干预研究偏倚风险工具进行偏倚风险分析
主要发现
- 选择透析的患者通常较选择保守治疗者更年轻、合并症更少、功能损害更少、衰弱更轻
- 未调整中位生存期从治疗决策或估算肾小球滤过率<15 mL/min/1.73 m2起算,透析组为20至67个月,保守治疗组为6至31个月
- 12项提供调整后死亡风险比的研究Meta分析显示,选择透析者与保守治疗者相比汇总调整HR为0.47(95%CI 0.39-0.57)
- 在高龄或严重合并症患者亚组中,死亡风险的降低仍具有统计学显著性,但分析为未调整
局限性
- 多数研究易发生选择偏倚和混杂
- 高偏倚风险和异质性报告使确定性结论无法得出,结果不能转化至个体层面
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Non-dialytic conservative care (CC) has been proposed as a treatment option for patients with kidney failure. This systematic review and meta-analysis aims at comparing survival outcomes between dialysis and CC in studies where patients made an explicit treatment choice. METHODS: Five databases were systematically searched from origin through 25 February 2021 for studies comparing survival outcomes among patients choosing dialysis versus CC. Adjusted and unadjusted survival rates were extracted and meta-analysis performed where applicable. Risk of bias analysis was performed according to the Cochrane Risk Of Bias In Non-randomized Studies of Interventions. RESULTS: A total of 22 cohort studies were included covering 21 344 patients. Most studies were prone to selection bias and confounding. Patients opting for dialysis were generally younger and had fewer comorbid conditions, fewer functional impairments and less frailty than patients who chose CC. The unadjusted median survival from treatment decision or an estimated glomerular filtration rate <15 mL/min/1.73 m2 ranged from 20 and 67 months for dialysis and 6 and 31 months for CC. Meta-analysis of 12 studies that provided adjusted hazard ratios (HRs) for mortality showed a pooled adjusted HR of 0.47 (95% confidence interval 0.39-0.57) for patients choosing dialysis compared with CC. In subgroups of patients with older age or severe comorbidities, the reduction of mortality risk remained statistically significant, although analyses were unadjusted. CONCLUSIONS: Patients opting for dialysis have an overall lower mortality risk compared with patients opting for CC. However, a high risk of bias and heterogeneous reporting preclude definitive conclusions and results cannot be translated to an individual level.
引用
- Voorend CGN, van Oevelen M, Verberne WR, et al. Survival of patients who opt for dialysis versus conservative care: a systematic review and meta-analysis. Nephrol Dial Transplant. 2022. PMID: 35195249. doi:10.1093/ndt/gfac010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。